Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma"
关于“新型 ATR 抑制剂 Elimusertib (BAY1895344) 在 ATRX 突变的子宫平滑肌肉瘤模型中显示出体内活性”的更正
期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2023.01.029
Harold, Justin; Bellone, Stefania; Manavell, Diego D; Mutlu, Levent; McNamara, Blair; Hartwich, Tobias Max Philipp; Zipponi, Margherita; Yang-Hartwich, Yang; Demirkiran, Cem; Verzosa, Miguel Skyler Z; Choi, Jungmin; Dong, Weilai; Buza, Natalia; Hui, Pei; Altwerger, Gary; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Santin, Alessandro D
